These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32691913)

  • 1. Is There a Value of Neurofilament Light as a Biomarker for Neurodegeneration in Parkinson's Disease?
    Zetterberg H
    Mov Disord; 2020 Jul; 35(7):1111-1112. PubMed ID: 32691913
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.
    Mollenhauer B; Dakna M; Kruse N; Galasko D; Foroud T; Zetterberg H; Schade S; Gera RG; Wang W; Gao F; Frasier M; Chahine LM; Coffey CS; Singleton AB; Simuni T; Weintraub D; Seibyl J; Toga AW; Tanner CM; Kieburtz K; Marek K; Siderowf A; Cedarbaum JM; Hutten SJ; Trenkwalder C; Graham D
    Mov Disord; 2020 Nov; 35(11):1999-2008. PubMed ID: 32798333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Author response to Wang et al. Blood neurofilament light chain in Parkinson's disease: A biological marker for prediction of cognitive impairment?
    Sampedro F; Kulisevsky J
    Parkinsonism Relat Disord; 2020 Aug; 77():159. PubMed ID: 32586750
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma neurofilament light chain levels are associated with depressive and anxiety symptoms in Parkinson's disease.
    Yin W; Zhu Y; Yang B; Wang F; Yin K; Zhou C; Ren H; Yang X
    Neurol Sci; 2022 Apr; 43(4):2839-2843. PubMed ID: 35088243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood neurofilament light chain in Parkinson's disease: A biological marker for prediction of cognitive impairment?
    Wang H; Wang W; Shi H; Han L
    Parkinsonism Relat Disord; 2020 Aug; 77():157-158. PubMed ID: 32563681
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum neurofilament light chain level as a biomarker of neurodegeneration and predictor of white-matter abnormality progression.
    Murthy JK; Das S
    Eur J Neurol; 2020 Oct; 27(10):e55. PubMed ID: 32526090
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurofilament Light: A Dynamic Cross-Disease Fluid Biomarker for Neurodegeneration.
    Zetterberg H
    Neuron; 2016 Jul; 91(1):1-3. PubMed ID: 27387643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK-PD).
    Buhmann C; Lezius S; Pötter-Nerger M; Gerloff C; Kuhle J; Choe CU
    Mov Disord; 2022 Feb; 37(2):435-436. PubMed ID: 35040209
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to: "Age-Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK-PD)".
    Aamodt WW; Chen-Plotkin AS
    Mov Disord; 2022 Feb; 37(2):436-437. PubMed ID: 35150470
    [No Abstract]   [Full Text] [Related]  

  • 11. High serum neurofilament light chain predicts a worse fate in early parkinsonism.
    Akhtar RS; Mano T
    Neurology; 2019 Mar; 92(13):595-596. PubMed ID: 30814326
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum neurofilament light chain as a preclinical marker of neurodegeneration.
    Parnetti L; Gaetani L; Di Filippo M
    Lancet Neurol; 2019 Dec; 18(12):1070-1071. PubMed ID: 31701888
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum neurofilament light chain studies in neurological disorders, hints for interpretation.
    Mariotto S; Sechi E; Ferrari S
    J Neurol Sci; 2020 Sep; 416():116986. PubMed ID: 32563076
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum neurofilament light as diagnostic biomarker for acute cerebral ischemia: a promising tool.
    Al-Khaled M
    Eur J Neurol; 2018 Apr; 25(4):609. PubMed ID: 29394470
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis.
    Hu X; Yang Y; Gong D
    Neurol Sci; 2017 Mar; 38(3):407-414. PubMed ID: 27896490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neurofilament light chain uncovers neurodegeneration early in the course of Alzheimer's disease.
    Brier MR; Day GS
    Brain; 2020 Dec; 143(12):3521-3522. PubMed ID: 33253358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference values for plasma neurofilament light chain in healthy Chinese children.
    Jin J; Cui Y; Hong Y; Zhou D; He N; Mao Z; Mao S
    Clin Chem Lab Med; 2022 Jan; 60(1):e10-e12. PubMed ID: 34449172
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurofilament light chain: An important step toward a disease biomarker in multiple sclerosis.
    Berger T; Stüve O
    Neurology; 2019 Mar; 92(10):451-452. PubMed ID: 30737335
    [No Abstract]   [Full Text] [Related]  

  • 19. CSF neurofilament light: A universal risk biomarker in multiple sclerosis?
    Khalil M; Salzer J
    Neurology; 2016 Sep; 87(11):1068-9. PubMed ID: 27521432
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis.
    Sako W; Murakami N; Izumi Y; Kaji R
    J Neurol Sci; 2015 May; 352(1-2):84-7. PubMed ID: 25868897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.